RAPT Therapeutics
Lori Lyons-Williams is an accomplished executive in the biotech and pharmaceutical industries, currently serving as President and CEO of Abdera Therapeutics since May 2022, and as an Independent Director at RAPT Therapeutics and Contineum Therapeutics. Previous roles include CEO of a stealth biotech company, President and COO of Neumora, and Chief Commercial Officer at Dermira, Inc. Notable board experience includes Independent Director at Five Prime Therapeutics since June 2019, focusing on protein therapeutics in immuno-oncology. Lori's extensive career at Allergan includes various leadership positions in sales and marketing. Educational qualifications include an MBA in Marketing and International Business from the University of Minnesota and a BA in Pre-Med from Virginia Tech.
This person is not in the org chart
This person is not in any offices
RAPT Therapeutics
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.